Lv11
94 积分 2024-03-26 加入
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
1个月前
已完结
Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development
1个月前
已完结
Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of Obesity
1个月前
已完结
Targeting the root cause of obesity-related comorbidities through weight independent and dependent actions on insulin sensitivity: Benefits of dual amylin and calcitonin receptor agonists
1个月前
已完结
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms
1个月前
已完结
Amylin and Leptin: Co-Regulators of Energy Homeostasis and Neuronal Development
1个月前
已完结
Insights into amylin–leptin synergy
1个月前
已完结
Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression
2个月前
已完结
Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli
2个月前
已完结
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study
2个月前
已完结
皖公网安备34019202002308
